111 related articles for article (PubMed ID: 35786686)
21. Bone resorptive activity of human peripheral blood mononuclear cells after fusion with polyethylene glycol.
Manrique E; Castillo LM; Lazala O; Guerrero CA; Acosta O
J Bone Miner Metab; 2017 Mar; 35(2):127-141. PubMed ID: 26969392
[TBL] [Abstract][Full Text] [Related]
22. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
Sugawara K; Hamada M; Hosoi S; Tamaoki T
Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505
[TBL] [Abstract][Full Text] [Related]
23. Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia.
Olivier BJ; Schoenmaker T; Mebius RE; Everts V; Mulder CJ; van Nieuwkerk KM; de Vries TJ; van der Merwe SW
Hepatology; 2008 Jan; 47(1):259-67. PubMed ID: 18022900
[TBL] [Abstract][Full Text] [Related]
24. Constitutive c-fos expression in osteoblastic MC3T3-E1 cells stimulates osteoclast maturation and osteoclastic bone resorption.
Kuroki Y; Shiozawa S; Sugimoto T; Kanatani M; Kaji H; Miyachi A; Chihara K
Clin Exp Immunol; 1994 Mar; 95(3):536-9. PubMed ID: 8137552
[TBL] [Abstract][Full Text] [Related]
25. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
Chu K; Snyder R; Econs MJ
J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
[TBL] [Abstract][Full Text] [Related]
26. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.
Kogawa M; Findlay DM; Anderson PH; Ormsby R; Vincent C; Morris HA; Atkins GJ
Endocrinology; 2010 Oct; 151(10):4613-25. PubMed ID: 20739402
[TBL] [Abstract][Full Text] [Related]
27. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
[TBL] [Abstract][Full Text] [Related]
28. Divergent resorbability and effects on osteoclast formation of commonly used bone substitutes in a human in vitro-assay.
Keller J; Brink S; Busse B; Schilling AF; Schinke T; Amling M; Lange T
PLoS One; 2012; 7(10):e46757. PubMed ID: 23071629
[TBL] [Abstract][Full Text] [Related]
29. The effects of varying degrees of allograft decalcification on cultured porcine osteoclast cells.
Herold RW; Pashley DH; Cuenin MF; Niagro F; Hokett SD; Peacock ME; Mailhot J; Borke J
J Periodontol; 2002 Feb; 73(2):213-9. PubMed ID: 11895288
[TBL] [Abstract][Full Text] [Related]
30. Relevance of osteoclast-specific enzyme activities in cell-based in vitro resorption assays.
Bernhardt A; Koperski K; Schumacher M; Gelinsky M
Eur Cell Mater; 2017 Jan; 33():28-42. PubMed ID: 28098926
[TBL] [Abstract][Full Text] [Related]
31. Influence of glucocorticoids on human osteoclast generation and activity.
Sivagurunathan S; Muir MM; Brennan TC; Seale JP; Mason RS
J Bone Miner Res; 2005 Mar; 20(3):390-8. PubMed ID: 15746983
[TBL] [Abstract][Full Text] [Related]
32. The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow.
Mbalaviele G; Chen H; Boyce BF; Mundy GR; Yoneda T
J Clin Invest; 1995 Jun; 95(6):2757-65. PubMed ID: 7769116
[TBL] [Abstract][Full Text] [Related]
33. Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation.
van der Pluijm G; Mouthaan H; Baas C; de Groot H; Papapoulos S; Löwik C
J Bone Miner Res; 1994 Jul; 9(7):1021-8. PubMed ID: 7942148
[TBL] [Abstract][Full Text] [Related]
34. A 3D scanning confocal imaging method measures pit volume and captures the role of Rac in osteoclast function.
Goldberg SR; Georgiou J; Glogauer M; Grynpas MD
Bone; 2012 Jul; 51(1):145-52. PubMed ID: 22561898
[TBL] [Abstract][Full Text] [Related]
35. Bone disease in nephropathic cystinosis is related to cystinosin-induced osteoclastic dysfunction.
Claramunt-Taberner D; Flammier S; Gaillard S; Cochat P; Peyruchaud O; Machuca-Gayet I; Bacchetta J
Nephrol Dial Transplant; 2018 Sep; 33(9):1525-1532. PubMed ID: 29365190
[TBL] [Abstract][Full Text] [Related]
36. New resorption assay with mouse osteoclast-like multinucleated cells formed in vitro.
Tamura T; Takahashi N; Akatsu T; Sasaki T; Udagawa N; Tanaka S; Suda T
J Bone Miner Res; 1993 Aug; 8(8):953-60. PubMed ID: 7692706
[TBL] [Abstract][Full Text] [Related]
37. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
Perez-Amodio S; Beertsen W; Everts V
J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporin-A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage.
Orcel P; Denne MA; de Vernejoul MC
Endocrinology; 1991 Mar; 128(3):1638-46. PubMed ID: 1999178
[TBL] [Abstract][Full Text] [Related]
39. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
[TBL] [Abstract][Full Text] [Related]
40. Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption.
Ha H; Shim KS; An H; Kim T; Ma JY
BMC Complement Altern Med; 2013 May; 13():112. PubMed ID: 23692684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
